Millennium Management
UTMD icon

Millennium Management’s Utah Medical Products UTMD Stock Holding History

Millennium Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Sell
6,773
-9,575
-59% -$603K ﹤0.01% 4852
2025
Q4 		$915K Sell
16,348
-4,208
-20% -$244K ﹤0.01% 4546
2025
Q3 		$1.29M Sell
20,556
-9,424
-31% -$557K ﹤0.01% 4412
2025
Q2 		$1.71M Sell
29,980
-2,028
-6% -$110K ﹤0.01% 4016
2025
Q1 		$1.79M Sell
32,008
-79
-0.2% -$4.73K ﹤0.01% 3883
2024
Q4 		$1.97M Buy
32,087
+6,975
+28% +$451K ﹤0.01% 3658
2024
Q3 		$1.68M Sell
25,112
-13,852
-36% -$940K ﹤0.01% 3860
2024
Q2 		$2.6M Sell
38,964
-11,638
-23% -$792K ﹤0.01% 3300
2024
Q1 		$3.6M Buy
50,602
+30,694
+154% +$2.3M ﹤0.01% 3211
2023
Q4 		$1.68M Sell
19,908
-2,081
-9% -$173K ﹤0.01% 3751
2023
Q3 		$1.89M Buy
21,989
+5,633
+34% +$520K ﹤0.01% 3599
2023
Q2 		$1.52M Buy
16,356
+8,205
+101% +$773K ﹤0.01% 3703
2023
Q1 		$772K Buy
+8,151
New +$749K ﹤0.01% 4316
2022
Q2 		– Sell
-3,465
Closed -$311K – 7533
2022
Q1 		$311K Buy
+3,465
New +$319K ﹤0.01% 5506
2021
Q3 		– Sell
-2,960
Closed -$252K – 7275
2021
Q2 		$252K Sell
2,960
-8,493
-74% -$735K ﹤0.01% 5866
2021
Q1 		$992K Sell
11,453
-3,949
-26% -$347K ﹤0.01% 4224
2020
Q4 		$1.3M Sell
15,402
-10,642
-41% -$907K ﹤0.01% 3561
2020
Q3 		$2.08K Buy
26,044
+5,139
+25% +$426K ﹤0.01% 2571
2020
Q2 		$1.85M Buy
+20,905
New +$1.88M ﹤0.01% 2594
2019
Q2 		– Sell
-2,289
Closed -$202K – 4478
2019
Q1 		$202K Buy
+2,289
New +$201K ﹤0.01% 3732
2018
Q4 		– Sell
-4,207
Closed -$396K – 4197
2018
Q3 		$396K Buy
4,207
+2,379
+130% +$227K ﹤0.01% 3361
2018
Q2 		$201K Buy
+1,828
New +$191K ﹤0.01% 3559
2018
Q1 		– Sell
-6,392
Closed -$520K – 4094
2017
Q4 		$520K Sell
6,392
-4,125
-39% -$322K ﹤0.01% 3075
2017
Q3 		$774K Sell
10,517
-4,975
-32% -$358K ﹤0.01% 2646
2017
Q2 		$1.12M Buy
15,492
+10,664
+221% +$702K ﹤0.01% 2388
2017
Q1 		$301K Sell
4,828
-249
-5% -$15.7K ﹤0.01% 3042
2016
Q4 		$369K Buy
+5,077
New +$330K ﹤0.01% 2809

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's UTMD Position: Q1 2026 in Review

Millennium Management reduced its Utah Medical Products (UTMD) stake by 59% in Q1 2026, selling an estimated $603K and leaving 6,773 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #4852.

Millennium Management first reported a position in UTMD in Q4 2016 and has held it in 27 quarters since. The position peaked at $3.6M in Q1 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Millennium Management held 6,773 shares of Utah Medical Products worth $420K as of Q1 2026.
  • Millennium Management sold 9,575 Utah Medical Products shares in Q1 2026, an estimated $603K.
  • Utah Medical Products made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4852 holding.
  • Millennium Management first reported a position in Utah Medical Products in Q4 2016 and has held it in 27 quarters since.
  • Millennium Management's Utah Medical Products position peaked at $3.6M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.